Nan Li

Nan Li is the Founder and Managing Partner at Dimension since July 2022 and has been actively involved in various organizations as an investor and board director or observer. Nan Li serves as a board director at Iterative Scopes, LabGenius, and Inato, contributing to advancements in computer vision for endoscopy, computational protein engineering, and a data-driven marketplace for clinical trial research sites. Additionally, Nan Li holds investments and board observer roles at Swiftscale Biologics, Anagenex, Octave, and Dyno Therapeutics, focusing on cell-free manufacturing, computational chemistry, mental health tech, and gene therapy discovery. Nan Li has a Bachelor of Science in Engineering degree in Computer Science from the University of Michigan.